The global monoclonal antibodies (mAbs) market is currently experiencing substantial growth and is projected to maintain a strong upward trajectory over the next decade. Valued at approximately USD 284.75 billion in 2025, the market is forecasted to expand at a compound annual growth rate (CAGR) of around 11.2% to reach USD 742.75 billion by 2034. Other recent reports provide a...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt